NCT05416554View on ClinicalTrials.gov

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Non Hodgkin Lymphoma
Interventions
BEHAVIORAL

Neuropsychological testing

Upon completion of the consent, the subject will be booked into an available 90 minute in-person or remote neuropsychological testing

Trial Locations (1)

94305

Stanford Cancer Center, San Francisco

All Listed Sponsors
lead

Stanford University

OTHER

NCT05416554 - Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford | Biotech Hunter | Biotech Hunter